Quotient Limited Reports Concordance Data from Extended Serological Disease Screening Benchmark Study
JERSEY, Channel Islands, Feb. 24, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, […]